Sleep-related breathing disorders refer to a spectrum of conditions in which normal breathing during sleep is disrupted, resulting in insufficient oxygen supply and fragmented rest. These disorders include obstructive sleep apnea, central sleep apnea, and hypoventilation syndromes, among others. Individuals affected often report persistent fatigue, difficulty concentrating, unrefreshing sleep, and unusual nighttime movements or pauses in breathing noticed by caregivers. These disruptions can strain the cardiovascular system, worsen metabolic health, and impair overall quality of life if left unaddressed. Diagnosing sleep-related breathing disorders involves detailed patient history, clinical evaluation, and objective monitoring through in-lab or home sleep studies, which track airflow patterns, oxygen levels, and respiratory effort over the course of the night. The results allow physicians to determine the specific type of disorder and its severity, guiding appropriate interventions.
Treatment strategies aim to restore normal respiratory patterns during sleep, enhance daytime alertness, and reduce the risk of secondary complications. Continuous or bilevel positive airway pressure devices are often used for obstructive forms, while targeted therapies such as supplemental oxygen or specialized ventilatory support may be indicated in other variants. Behavioral interventions—including weight optimization, sleep position adjustment, avoidance of alcohol or sedatives before bedtime, and establishing regular sleep routines—complement device-based management. Oral or dental appliances can be effective for patients with mild obstruction who cannot tolerate standard devices. Coordinated care by pulmonologists, sleep specialists, and allied health providers ensures individualized management, continuous monitoring, and education on adherence, leading to improved respiratory stability, better sleep quality, and reduced long-term health risks associated with sleep-related breathing disorders.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation